When prescribing opioid analgesics for chronic pain, there is always the possibility of overdose. People often indulge in such medicine, making prescription drug abuse one of the biggest threats in the United States.
One of the important weapons to fight the opioid epidemic is naloxone. It is an opioid antagonist that is widely used by physicians and emergency medical service providers over the years as an excessive risk reduction intervention for opioid overdose patients.
According to the report of the Centers for Disease Control and Prevention (CDC), the use of naloxone is widely endorsed for the life-saving ability of naloxone. According to the report, overdose of prescription drugs, recognition and response to their symptoms, and pathways to opioid overdose therapy to administrators are essential for battle against prescription drug abuse. According to the CDC report, "Public health critical intervention to reduce mortality".
Community based program
This report acknowledges that in areas where community-based programs are implemented, opioid mortality rates are declining markedly. These programs, including naloxone, need to participate in training to individuals at risk and their loved ones to prevent overdosing, and they need to spread to counter the epidemic.
To support beneficial laws
The local laws of various states are extremely helpful in solving the problem of overdose of opioids. Some states offer exemptions from the prosecution to motivate people for help in case of excessive emergencies. It makes it possible for overdosed people to seek treatment without any fear.
Studies have shown that people suffering from opioid overdose often refrain from calling emergency services due to the fear of arrest. The implementation of the Good Samaria Act in Washington shows that the number of cases where drug users have asked for help without hesitation has increased rapidly.
By introducing excessive intake prevention activities, you can walk a long way, including education, training, responding to safe and effective acute overdose events and introducing treatment modalities.
Looking at the importance of naloxone, 2012 Food and Drug Administration (FDA), Health Consulting Office (OASH), National Institute of Health (NIH), Substance Abuse and Mental Health Service Administration (SAMHSA), and CDC, We will consider ways to expand access to naloxin and plan to make it safer and easier to use. FDA and NIH are cooperating with pharmaceutical manufacturers to support the development of new formulations of naloxone that can be used as nasal sprays and autoinjectors.
HHS also provides financial aid and technical assistance to raise awareness of overdose prevention and increase the number of people who respond to overdose, such as first responders who are not responding to overdose prevention. Extensive research is being carried out by the CDC in order to clearly understand the situation of excessive administration and risk factors.
NIH grants easy accessible small business innovation research to develop a comprehensive computer-assisted training curriculum on overdose for public safety personnel (PSP) including police, firefighters, emergency medical technicians We also provide funds for money.
The major activities of overdose prevention permitted in the report are identified as opportunities to expand current efforts to enhance overdose intake and improve access and use to naloxone.
Several suggestions have been made in the CDC report to address national prescription drug abuse. They include:
- Expand efforts to support the development of naloxone formulations such as nasal spray and automatic injector formulations.
- Cooperate with national, state and local EMS and other initial response organizations to resolve information on the use of naloxone.
- Evaluate the naloxon's program and better understand what state and how it is most effectively used.
- Examine the impact of exemption from the prosecution.
